对150例无甲状腺疾病的肝硬化病人进行血清T_3、T_4、rT_3测定,其中8例加测FT_3、FT_4及TSH。结果:肝硬化病人血清T_3、T_4降低,rT_3升高,与正常对照值比较,P 值均<0.01,差异有高度显著性,肝硬化患者低T_3、T_4及高rT_3血症与肝功能损害呈正相关。有肝昏迷、消化道出血、肝癌严重并发症时,低T_3、高rT_3血症尤为显著,P<0.05,且多伴有低T_4血症,P<0.01。血T_4愈低死亡率愈高,可作为肝硬化患者预后的估价。 Serum levels of T_3, T_4 and rT_3 were measured in 150 patients with thyroid disease without cirrhosis. Among them, 8 were tested with FT_3, FT_4 and TSH. Results: The serum levels of T_3 and T_4 were decreased and rT_3 were increased in patients with cirrhosis, P <0.01, the difference was highly significant. The low T_3, T_4 and high rT_3 in patients with liver cirrhosis and liver dysfunction were positive Related. Hepatic coma, gastrointestinal bleeding, serious complications of liver cancer, low T_3, high rT_3 hyperlipidemia is particularly significant, P <0.05, and more accompanied by low T_4 blood disease, P <0.01. The lower the blood T_4 lower mortality, liver cirrhosis can be used as the prognosis of the valuation.